Examining molecular biomarkers to diagnose vascular cognitive impairment and dementia

A recent study from UNSW Sydney’s Center for Healthy Brain Aging (CHeBA) suggests that the research pace into understanding biomarkers for the diagnosis of vascular cognitive impairment and dementia needs to be accelerated.

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart